Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA international travel policy

Executive Summary

International travel for FDA employees should be restricted to "essential" meetings in these non-"routine" times, Commissioner McClellan clarifies in March 24 memo. "Examples of 'essential' would include meetings where significant regulatory policy decisions will be made that will impact the Agency directly and where the policy decision would be expected to be different were FDA personnel not there to represent the Agency's position. 'Essential' does not include routine attendance at a conference, routine speeches, outreach, training, routine meetings of working groups, etc.," the memo says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS041520

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel